[1]
Kurbatov, L., Radko, S. , Khmeleva, S., Timoshenko, O. and Lisitsa, A. 2022. Evaluation of the Collateral Activity of CRISPR/Cas13a-Ribonuclease on the Agilent 2100 Bioanalyzer. Biomedical Chemistry: Research and Methods. 3, 3 (Jun. 2022), e00169. DOI:https://doi.org/10.18097/BMCRM00133.